Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 8/20 | 0.94 |
| ▸ | ITPR2 | Q14571 | 4/20 | 0.94 |
| ▸ | ITPR1 | Q14643 | 4/20 | 0.94 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.94 |
| ▸ | AKT1 | P31749 | 1/20 | 0.94 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.84 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ionositol (1,3,4,5,6) P5 SCHEMBL406795 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL29635093 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL29635038 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL29635044 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL2710469 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL15209904 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL5159171 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL30469421 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL13951027 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL357421 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569555-B2 | Organically modified mineral micro-particles, methods of preparing the same and uses thereof | CRODA INTERNATIONAL PLC (GB) | 2026-03-10 | — | — | US | claimed |
| EP-3883655-B1 | EMULSIONS WITH A HIGH INTERNAL OIL PHASE | OREAL (FR) | 2025-02-19 | — | — | EP | claimed |
| WO-2024216202-A2 | FRET BIOSENSOR RECOMBINANT PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-17 | — | — | WO | claimed |
| EP-3699271-B1 | GRANULE AND PELLET COMPOSITIONS COMPRISING PHYTASE AND PHYTIC ACID AND PREPARATION METHOD | DANISCO US INC (US) | 2024-09-25 | — | — | EP | claimed |
| EP-3989914-B1 | COMPOSITION COMPRISING INGREDIENTS FOR DIC-GEL AND POLYOL | OREAL (FR) | 2024-07-24 | — | — | EP | claimed |
| US-11833234-B2 | Emulsions with a high internal oil phase | L'OREAL (FR) | 2023-12-05 | — | — | US | claimed |
| WO-2023156298-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A POLYIONIC COMPLEX | L'OREAL (FR) | 2023-08-24 | — | — | WO | claimed |
| US-20220362128-A1 | COMPOSITION COMPRISING INGREDIENTS FOR DIC-GEL AND POLYOL | L'OREAL (FR) | 2022-11-17 | — | — | US | claimed |
| US-20220144747-A1 | SHIKIMATE ANALOGUES AND METHODS OF USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2022-05-12 | — | — | US | claimed |
| EP-3989914-A1 | COMPOSITION COMPRISING INGREDIENTS FOR DIC-GEL AND POLYOL | L'OREAL (FR) | 2022-05-04 | — | — | EP | claimed |
| WO-2020045134-A1 | SELF-HEALING OR SELF-REPAIRING FILM FORMING COMPOSITION | L'OREAL (FR) | 2020-03-05 | — | — | WO | claimed |
| WO-2020045251-A1 | EMULSIONS WITH A HIGH INTERNAL OIL PHASE | OREAL (FR) | 2020-03-05 | — | — | WO | claimed |
| US-20200048498-A1 | CHEMICAL MECHANICAL POLISHING SLURRY COMPOSITION | DONGJIN SEMICHEM CO., LTD. (KR) | 2020-02-13 | — | — | US | claimed |
| US-20200031791-A1 | SHIKIMATE ANALOGUES AND METHODS OF USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2020-01-30 | — | — | US | claimed |
| WO-2019201710-A1 | ORGANICALLY MODIFIED MINERAL MICRO-PARTICLES, METHODS OF PREPARING THE SAME AND USES THEREOF | CRODA DENMARK A/S (DK) | 2019-10-24 | — | — | WO | claimed |
| EP-3556728-A1 | ORGANICALLY MODIFIED MINERAL MICRO-PARTICLES, METHODS OF PREPARING THE SAME AND USES THEREOF | Croda Denmark A/S (SE) | 2019-10-23 | — | — | EP | claimed |
| US-20130227716-A1 | METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2013-08-29 | — | — | US | claimed |
| US-20130012687-A1 | INDUCIBLE SELF-CLEAVING PROTEASE TAG AND METHOD OF PURIFYING RECOMBINANT PROTEINS USING THE SAME | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2013-01-10 | — | — | US | claimed |
| WO-2011034622-A9 | INDUCIBLE SELF-CLEAVING PROTEASE TAG AND METHOD OF PURIFYING RECOMBINANT PROTEINS USING THE SAME | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2011-06-23 | — | — | WO | claimed |
| WO-2011034622-A2 | INDUCIBLE SELF-CLEAVING PROTEASE TAG AND METHOD OF PURIFYING RECOMBINANT PROTEINS USING THE SAME | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2011-03-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11833234-B2 | Emulsions with a high internal oil phase | OSTC, INO80C, F12 | ITPR3 442/4885ITPR2 753/4885ITPR1 611/4885 |
| US-12569555-B2 | Organically modified mineral micro-particles, methods of preparing the same and uses thereof | IPMK, ITPA, ITPR1 | ITPR3 5/4885ITPR2 6/4885ITPR1 3/4885 |
| US-20200031791-A1 | SHIKIMATE ANALOGUES AND METHODS OF USE | GRIK3, SYMPK, SIK3 | ITPR3 1191/4885ITPR2 1834/4885ITPR1 2033/4885 |
| US-20220362128-A1 | COMPOSITION COMPRISING INGREDIENTS FOR DIC-GEL AND POLYOL | PARG, DSC1, DAD1 | ITPR3 852/4885ITPR2 1321/4885ITPR1 1494/4885 |
| US-20220144747-A1 | SHIKIMATE ANALOGUES AND METHODS OF USE | GRIK5, GRIK1, GRIK3 | ITPR3 1373/4885ITPR2 1682/4885ITPR1 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.